IDEXX Laboratories, Inc. is a U.S. healthcare company, that currently leads the veterinary industry developing diagnostics tools to satisfy veterinarians’ everyday needs. IDEXX has delivered solid and ...

Fundsmith, an investment management firm based in London, has released its annual 2025 investor letter for its “Fundsmith ...

ImageVue DR50 Plus introduces high-definition diagnostic imaging at the lowest dose of radiation, accelerating diagnosis and improving staff safety.

IDEXX Laboratories has designated Michael Erickson to succeed Jonathan Mazelsky at the helm of the pet healthcare company later this year.

IDEXX Laboratories, Inc. (IDXX) is a multinational healthcare company specializing in the development, manufacture, and ...

While they might not represent the most exciting field in the biotech space, animal healthcare companies have been a steady, consistent source of growth in what's often a turbulent market. One company ...

In a report released yesterday, Jonathan Block from Stifel Nicolaus maintained a Hold rating on Idexx Laboratories (IDXX – Research Report), with a price target of $525.00. The company’s shares closed ...

In the latest quarter, 4 analysts provided ratings for IDEXX Laboratories (NASDAQ:IDXX), showcasing a mix of bullish and bearish perspectives. The table below summarizes their recent ratings, ...

WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, today announced third quarter results. Third Quarter Results The Company ...

IDEXX Laboratories, a leader in pet diagnostic and software products, is targeting 10%+ organic sales growth and 15-20% EPS growth, making it a high-quality company. The company is focusing on ...

WESTBROOK, Maine--(BUSINESS WIRE)--IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, will participate in the Stifel Jaws & Paws Conference on Wednesday, May 31, ...